Epigral Limited

• Epigral to host investor plant visit at Dahej facility on October 22
  scanx.trade · 21 Oct 2026
• EPIGRAL Q2 2026 Earnings: EPS of ₹76.95 as Revenue Holds Near Flat at ₹2,495.5 Crore - Analyst Earnings Estimate
  https://www.siam.in/ · 18 Oct 2026
• Epigral EPIGRAL Reg 74(5) Certificate Q2 FY27 Filed
  Kalkine India · 15 Oct 2026
• Epigral Limited (EPIGRAL.NS) Slips 0.60% to ₹1030 as Traders Watch ₹978.5 Support - Channel Breakout
  https://www.siam.in/ · 07 Oct 2026
• Epigral Targets Rs. 50 bn Revenue by FY31 Through Capacity Expansion
  Construction World · 30 Sep 2026
• Epigral eyes ₹5,000 crore revenue by FY31 on chemical capacity expansion
  Indiatimes · 29 Sep 2026
• Epigral Targets ₹5,000 Crore Revenue By FY31 Supported By Capacity Scale-Ups
  Sahi · 28 Sep 2026
• Jubilant Ingrevia vs Epigral vs Ami Organics: Comparison
  Univest · 28 Sep 2026
• Capacity scale-ups to drive Epigral's Rs 5,000 crore target by FY31: CMD Maulik Patel
  The Economic Times · 27 Sep 2026
• Epigral: Best Stock in Its Sector? Key Metrics
  Univest · 25 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →